Matt Ferriday announced as General Manager for LEO Pharma UK

Maidenhead, Berkshire, United Kingdom, 01 April 2026

LEO Pharma, a leader in medical dermatology, has today announced the appointment of Matt Ferriday as General Manager for LEO Pharma United Kingdom.

Matt joins LEO Pharma from Ipsen Biopharma, where he held senior leadership roles across Rare Diseases and Neuroscience. A senior commercial leader with nearly two decades of experience, he has delivered high performance across in‑country, regional and global roles, combining strategic leadership with strong operational execution. Widely recognised for driving sustainable growth, successful first‑in‑class launches and revitalising established franchises, Matt is passionate about addressing health inequity and making a positive impact on public health and is excited about the next chapter with LEO Pharma.

Commenting on his appointment, Matt said:

“I’m delighted to be joining LEO Pharma at such a positive time for the UK business. There is a strong team in place, a clear sense of purpose, and meaningful momentum to build on. My key priority as I join LEO Pharma UK is to continue to build our reputation and recognition as a medical leader in dermatology, working closely with internal and external stakeholders to deliver positive impact for people living with skin conditions.”

Matt is in role as General Manager for LEO Pharma UK as of 1 April 2026.